RxDoctor Payments Data

Denise McHugh, MD

Obstetrics & Gynecology · Nashua, NHNPI 1982763611

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 42 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by AbbVie at 57.4% of the total. 2023 is the largest year on record at $314, 4.4 times the $72 reported in 2019.

$798in general payments, 2019–2025

Across 42 payments — averaging $19.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$459
  • Therapeuticsmd, Inc.$164
  • GSK$95
  • Bayer$25
  • Evofem Biosciences, Inc.$24
  • Merck$18
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$798100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)30$459
Therapeuticsmd, Inc.7$164
GSK1$95
Bayer1$25
Evofem Biosciences, Inc.1$24
Merck1$18
Coopersurgical, Inc.1$14

How this compares

$798 in reported general payments places this provider in the 85th percentile of 186 obstetrics & gynecology providers in New Hampshire.

See all obstetrics & gynecology providers in New Hampshire

Medicare billing

Part B allowed, 2024
$2,119
Medicare patients
23
Services billed
30

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol38$3,320

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Nashua

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →